Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer

OBJECTIVE. The ideal number of neoadjuvant chemotherapy (NACT) cycles prior to interval tumor-reductive surgery (iTRS) for advanced ovarian cancer is poorly defined. We sought to assess survival stratified by number of NACT cycles and residual disease following iTRS in patients with advanced ovarian...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Gynecol Oncol
Auteurs principaux: Nitecki, Roni, Fleming, Nicole D., Fellman, Bryan M., Meyer, Larissa A., Sood, Anil K., Lu, Karen H., Rauh-Hain, J. Alejandro
Format: Artigo
Langue:Inglês
Publié: 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165031/
https://ncbi.nlm.nih.gov/pubmed/33867146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2021.04.012
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires